Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Marginal Bone Level Change clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Marginal Bone Level Change: 1 US clinical trial tracked, none currently recruiting.

Marginal Bone Level Change is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Nobel Biocare, running 1 of these trials.

Enrollment posture brief

Registry condition marginal-bone-level-change

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Marginal Bone Level Chan (th…0%
Open-enrollment share among volume-matched conditions near Marginal Bone Level Change

Marginal Bone Level Change has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Marginal Bone Level Change on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Marginal Bone Level Change is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Nobel Biocare 1 trials

Named interventions

Most-linked intervention names on Marginal Bone Level Change records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Nobel Biocare N1 TiUltra TCC implants Device
1 trials
NobelReplace CC TiUltra implants Device
1 trials
NobelParallel CC TiUltra implants Device
1 trials
NobelActive TiUltra implant Device
1 trials

US sites by state

Facility locations filed on Marginal Bone Level Change trials. A trial with sites in several states counts in each.

Oregon 1 trials
New York 1 trials
Illinois 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Marginal Bone Level Change page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Marginal Bone Level Change trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Nobel Biocare sponsors the most Marginal Bone Level Change trials on record, review their full trial history before evaluating a specific study. See Nobel Biocare's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Marginal Bone Level Change condition card totals 1 registered trials; most-linked intervention Nobel Biocare N1 TiUltra TCC implants; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.